Foundation Medicine is transforming cancer care by providing patients, physicians and researchers with a deep understanding of the genomic mutations that drive cancer.

FoundationOne®CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors.

Foundation Medicine is committed to excellent service. If you have questions or need assistance, call or email our client services team.

2024年10月17日 · We are Transforming Cancer Care Since Foundation Medicine’s inception, the people and families affected by cancer have inspired us every day in our commitment to transform cancer care.